Home › Agent Hub › Agent Tools › Part D coverage by drug › Livalo
Agent Tools
Livalo is a brand of pitavastatin. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 900 of 5,492 Medicare Part D and Medicare Advantage drug plans (16.4%) list Livalo on their formulary, across 8 of 286 formularies. The most common placement is tier 3 (900 plans, 100% of those covering it). 0 of the covering plans require prior authorization (0%), 0 step therapy and 886 a quantity limit. Generic pitavastatin is on 4,169 of 5,492 plans (75.9%).
26 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $0, 14 of them $0; 874 charge coinsurance instead — median 22% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 904 of 5,496 plans covered it (16.4%); 2027: 900 of 5,492 (16.4%).
Of 4,367 plans offered in both years, 0 added it to the formulary and 0 dropped it.
Among plans covering it both years, 0 moved it to a higher tier and 0 to a lower one; 0 added prior authorization and 0 removed it.
| Tier | Plans |
|---|---|
| Tier 3 | 900 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 41 of 323 | 12.7% | 0% |
| Medicare Advantage with drugs (MA-PD) | 486 of 3,200 | 15.2% | 0% |
| Special needs plans (SNP) | 373 of 1,969 | 18.9% | 0% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 0 of 846 | No tier listed | 0 |
| UnitedHealthcare | 796 of 830 | Tier 3 | 0 |
| Devoted Health | 0 of 728 | No tier listed | 0 |
| Aetna Medicare | 0 of 631 | No tier listed | 0 |
| Wellcare | 0 of 268 | No tier listed | 0 |
| HealthSpring | 0 of 226 | No tier listed | 0 |
| Kaiser Permanente | 0 of 112 | No tier listed | 0 |
| SCAN Health Plan | 0 of 83 | No tier listed | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 0 of 80 | No tier listed | 0 |
| Alignment Health Plan | 0 of 77 | No tier listed | 0 |
| Anthem Blue Cross and Blue Shield | 0 of 74 | No tier listed | 0 |
| Wellpoint | 0 of 63 | No tier listed | 0 |
| Priority Health Medicare | 0 of 40 | No tier listed | 0 |
| CarePlus Health Plans, Inc. | 0 of 37 | No tier listed | 0 |
| Zing Health | 0 of 36 | No tier listed | 0 |
| Capital Blue Cross | 0 of 35 | No tier listed | 0 |
| Prominence Health Plan | 29 of 29 | Tier 3 | 0 |
| Medica | 0 of 27 | No tier listed | 0 |
| Anthem HealthKeepers | 0 of 26 | No tier listed | 0 |
| Blue Cross Blue Shield of Michigan | 26 of 26 | Tier 3 | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 15 of 114 | 13.2% |
| Alaska | 1 of 9 | 11.1% |
| American Samoa | 1 of 1 | 100% |
| Arizona | 19 of 147 | 12.9% |
| Arkansas | 11 of 85 | 12.9% |
| California | 41 of 397 | 10.3% |
| Colorado | 21 of 106 | 19.8% |
| Connecticut | 8 of 54 | 14.8% |
| Delaware | 8 of 43 | 18.6% |
| District of Columbia | 5 of 12 | 41.7% |
| Florida | 60 of 545 | 11% |
| Georgia | 19 of 149 | 12.8% |
| Guam | 1 of 1 | 100% |
| Hawaii | 7 of 50 | 14% |
| Idaho | 15 of 45 | 33.3% |
| Illinois | 20 of 132 | 15.2% |
| Indiana | 22 of 138 | 15.9% |
| Iowa | 12 of 64 | 18.8% |
| Kansas | 14 of 84 | 16.7% |
| Kentucky | 20 of 121 | 16.5% |
| Louisiana | 22 of 125 | 17.6% |
| Maine | 11 of 52 | 21.2% |
| Maryland | 5 of 49 | 10.2% |
| Massachusetts | 10 of 89 | 11.2% |
| Michigan | 53 of 182 | 29.1% |
| Minnesota | 8 of 63 | 12.7% |
| Mississippi | 18 of 104 | 17.3% |
| Missouri | 28 of 170 | 16.5% |
| Montana | 3 of 27 | 11.1% |
| Nebraska | 8 of 51 | 15.7% |
| Nevada | 29 of 100 | 29% |
| New Hampshire | 6 of 25 | 24% |
| New Jersey | 13 of 73 | 17.8% |
| New Mexico | 29 of 68 | 42.6% |
| New York | 28 of 215 | 13% |
| North Carolina | 28 of 176 | 15.9% |
| North Dakota | 5 of 26 | 19.2% |
| Northern Mariana Islands | 1 of 1 | 100% |
| Ohio | 27 of 171 | 15.8% |
| Oklahoma | 19 of 81 | 23.5% |
| Oregon | 9 of 92 | 9.8% |
| Pennsylvania | 34 of 323 | 10.5% |
| Puerto Rico | 1 of 64 | 1.6% |
| Rhode Island | 10 of 29 | 34.5% |
| South Carolina | 10 of 89 | 11.2% |
| South Dakota | 3 of 30 | 10% |
| Tennessee | 22 of 156 | 14.1% |
| Texas | 84 of 407 | 20.6% |
| U.S. Virgin Islands | 1 of 1 | 100% |
| Utah | 14 of 53 | 26.4% |
| Vermont | 1 of 14 | 7.1% |
| Virginia | 36 of 144 | 25% |
| Washington | 24 of 114 | 21.1% |
| West Virginia | 10 of 69 | 14.5% |
| Wisconsin | 22 of 96 | 22.9% |
| Wyoming | 3 of 13 | 23.1% |
Medicare Part D paid for 298,451 30-day fills of Livalo in 2024 for about 37,762 enrollees, at an average total cost of $303.05 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Livalo and the rest of a client's list on every plan in their county.
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.